ARCHIVES

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

This article is from The Cancer Letter archive.

Vol. 01 No. 25 | June 20, 1975

Download PDF Visit The Full Archive

Related Articles

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach

February 7, 2014

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980

In Brief: James Downing named CEO of St. Jude

June 27, 2014

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008

Silicone Implants Not Linked To Increased Risk Of Death

May 25, 2001